(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the spinal cord stimulators market include catering to the rising chronic pain and neuropathy cases, advancements in rechargeable devices, and regional growth prospects, especially in North America driven by supportive regulations. Enhanced device features and successful market approvals further fuel its demand.

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets's offering.

The global spinal cord stimulators market is poised for significant growth, projected to expand from USD 3.43 billion in 2024 to USD 7.24 billion by 2032, driven by a CAGR of 9.83%.

This surge is attributed to the rising incidence of chronic pain and neuropathic disorders, particularly impacting regions like the shoulders, legs, and knees. The prevalence of degenerative spine conditions such as diabetic neuropathy, along with failed back surgery syndrome, also contributes to market expansion. Government regulations favoring the commercialization of advanced spinal cord stimulation devices and the growing geriatric population further bolster market growth.

Spinal cord stimulators provide a minimally invasive and drug-free solution for pain management. They work by transmitting electrical impulses to the spinal cord, effectively blocking pain signals. With chronic pain affecting 843 million people worldwide by 2050, the demand for effective pain management solutions such as spinal cord stimulators will continue to rise.

Regionally, North America is expected to lead the market by 2024, driven by an increase in chronic pain cases and innovations in pain management therapies. Government initiatives and favorable reimbursement policies enhance patient access, supporting this growth. Similarly, key industry players in the region are advancing product development, with next-generation spinal cord stimulators coming to market.

Key players in the market include Boston Scientific Corporation, Medtronic, Abbott, Nevro Corp, among others. In December 2022, Abbott Laboratories gained FDA approval for the Eterna spinal cord stimulation system, highlighting ongoing advancements and approvals in the field.

The rechargeable segment of the market is anticipated to hold a significant revenue share, primarily due to its cost-effectiveness and convenience in therapy management. For instance, Medtronic's announcement of CE Mark approval for the Inceptive closed-loop rechargeable system demonstrates the innovations pushing market growth.

Furthermore, the market for spinal cord stimulators will be shaped by strategic developments, including product launches, mergers, and partnerships among key players. Notably, Nevro's recent milestone of receiving the CE mark for its HFX iQ system underlines the dynamic and competitive nature of this sector.

The demand for efficient pain management solutions, coupled with technological innovations and favorable market conditions, supports a positive outlook for the spinal cord stimulators market through 2032. Stakeholders and new entrants can leverage these growth dynamics to capitalize on emerging opportunities within the market.

Key Topics Covered:

1. Spinal Cord Stimulators Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Spinal Cord Stimulators Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Spinal Cord Stimulators Market Key Factors Analysis

• 5.1. Spinal Cord Stimulators Market Drivers
  • 5.1.1. Growing burden of chronic pain and degenerative spine conditions
  • 5.1.2. Increasing product development activities
  • 5.1.3. Increasing geriatric population
• 5.2. Spinal Cord Stimulators Market Restraints and Challenges
  • 5.2.1. High cost of spinal cord stimulator procedures
  • 5.2.2. Complications associated with technologically advanced devices
• 5.3. Spinal Cord Stimulators Market Opportunities
  • 5.3.1. Development of non-invasive, compact, and advanced devices

6. Spinal Cord Stimulators Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Spinal Cord Stimulators Market Assessment

• 7.1. By Product Type
  • 7.1.1. Rechargeable
  • 7.1.2. Non-Rechargeable
  • 7.1.3. Others
• 7.2. By Application
  • 7.2.1. Failed Back Syndrome (FBS)
  • 7.2.2. Degenerative Disk Disease (DDD)
  • 7.2.3. Complex Regional Pain Syndrome (CRPS)
  • 7.2.4. Others
• 7.3. By End-User
  • 7.3.1. Hospital & Clinics
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia-Pacific
  • 7.4.4. Rest of the World (RoW)

8. Spinal Cord Stimulators Market Company and Product Profiles

• 8.1. Boston Scientific Corporation
• 8.2. Medtronic PLC
• 8.3. Abbott Laboratories
• 8.4. Nevro Corp
• 8.5. Cirtec Medical
• 8.6. Stimwave LLC.
• 8.7. NeuroSigma, Inc.
• 8.8. Synapse Biomedical, Inc.
• 8.9. Greatbatch, Inc.
• 8.10. Saluda Medical Pty Ltd.
• 8.11. Beijing PINS Medical Co., Ltd.

9. KOL Views

10. Project Approach

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN22102025004107003653ID1110231326